CAS RN: 62211-93-2
1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250921 |
100g |
In stock |
Shanghai, Tianjin, Chengdu | Inquiry |
| Batchno.20260527 |
1kg |
In stock |
Shanghai | Inquiry |
| Batchno.20260215 |
25g |
In stock |
Shanghai | Inquiry |
| Batchno.20250703 |
500g |
In stock |
Shanghai | Inquiry |
| Batchno.20260327 |
5g |
In stock |
Shanghai, Shenzhen | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 10g, 25g, 5g, 100g
- Available purity: ≥98%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 62211-93-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 10g |
≥98% |
5
In Stock
|
Hong Kong |
Inquiry |
| 25g |
≥98% |
4
In Stock
|
Hong Kong |
Inquiry |
| 5g |
≥98% |
2
In Stock
|
Shanghai |
Inquiry |
| 100g |
≥98% |
2
In Stock
|
Shenzhen |
Inquiry |
62211-93-2 / [(2R,3R,4R)-4,5-diacetyloxy-2-methyloxolan-3-yl] acetate
Standard CAS: 62211-93-2
Multi CAS: Yes
Basic Information
CAS
62211-93-2
Multi CAS
Yes
Molecular Formula
C11H16O7
Molecular Weight
260.240000
Exact Mass
260.089603
InChI
InChI=1S/C11H16O7/c1-5-9(16-6(2)12)10(17-7(3)13)11(15-5)18-8(4)14/h5,9-11H,1-4H3/t5-,9-,10-,11?/m1/s1
InChIKey
NXEJETQVUQAKTO-ZBCCYFLUSA-N
Computed Properties
Structural Parameters
Heavy atom count
18
Fraction Csp3
0.73
Rotatable bonds
3
H-bond acceptors
7
Molar refractivity
57.21
TPSA
88.13
LogP / Solubility
WLOGP
0.16
MLOGP
0.15
XLogP3
0.3
Consensus LogP
0.2
Log S (ESOL)
-1.35
Class (ESOL)
Soluble
Log S (Ali)
-1.81
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.84
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.2
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
3.5